Article
FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide.
Journal of molecular and cellular cardiology - 1 Jan 2026
Sánchez-López David, García-Vega David, Viñuela J E, Ferreirós-Vidal Isabel, Iglesias-Álvarez Diego, Martínez-Cereijo José Manuel, Reija-López Laura, Fernández-González Ángel L, González-Juanatey José R, Eiras Sonia
Abstract excerpt
Dysfunctional epicardial adiposity is a risk factor for coronary artery disease (CAD). Its genesis is associated with an upregulation of fatty acid binding protein 4 (FABP4) levels, which might exert paracrine inflammatory and atherogenic mechanisms on the cardiovascular system. We aimed to study the prognosis of patients with high systemic FABP4, its association with a neutrophil proatherogenic phenotype,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
